Literature DB >> 14694038

Urgent endovascular revascularization for symptomatic intracranial atherosclerotic stenosis.

R Gupta1, H C Schumacher, S Mangla, P M Meyers, H Duong, A G Khandji, R S Marshall, J P Mohr, J Pile-Spellman.   

Abstract

BACKGROUND: Endovascular revascularization for intracranial atherosclerotic stenoses is being increasingly performed at major medical centers and has been reported to be technically feasible and safe. The authors report their experience with patients who underwent such a procedure for impending stroke and neurologic instability.
METHOD: All 18 patients (21 intracranial lesions) treated between 1997 and 2002 at the authors' institution with endovascular revascularization were retrospectively reviewed. Each patient had failed maximal medical therapy and was thought to be at high risk for an imminent stroke.
RESULTS: Endovascular revascularization was performed on eight distal internal carotid artery lesions, six middle cerebral artery lesions, four intracranial vertebral artery lesions, and three basilar artery lesions. Recanalization was complete in 5 arteries (Thrombolysis in Myocardial Infarction [TIMI] Grade III), partial in 14 arteries (TIMI Grade II), and complete occlusion (TIMI 0) developed in 1 artery. In a patient with a tight basilar stenosis, no angioplasty could be performed because of the inability to cross the stenosis with the guidewire. Major periprocedural complications occurred in 9 (50%) patients: intracranial hemorrhage in 3 (17%), disabling ischemic stroke in 2 (11%), and major extracranial hemorrhage in 4 (22%). Three patients died: one from intracerebral hemorrhage and two from cardiorespiratory failure.
CONCLUSIONS: Endovascular revascularization of intracranial vessels is technically feasible and may be performed successfully. However, periprocedural complication and fatality rates in neurologically unstable patients are high. The results suggest that patient selection, procedure timing, and periprocedural medical management are critical factors to reduce periprocedural morbidity and mortality.

Entities:  

Mesh:

Year:  2003        PMID: 14694038     DOI: 10.1212/01.wnl.0000103900.65021.5b

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  34 in total

Review 1.  Symptomatic intracranial arterial disease: incidence, natural history, diagnosis, and management.

Authors:  Ananth K Vellimana; Andria L Ford; Jin-Moo Lee; Colin P Derdeyn; Gregory J Zipfel
Journal:  Neurosurg Focus       Date:  2011-06       Impact factor: 4.047

Review 2.  [Stents in the treatment of intracranial atherosclerotic stenoses].

Authors:  R du Mesnil de Rochemont; M Sitzer; F E Zanella; J Berkefeld
Journal:  Radiologe       Date:  2004-10       Impact factor: 0.635

3.  Stenting for the treatment of high-grade intracranial stenoses.

Authors:  S Lanfranconi; A Bersano; V Branca; E Ballabio; M Isalberti; R Papa; L Candelise
Journal:  J Neurol       Date:  2010-07-04       Impact factor: 4.849

4.  Techniques for intracranial stent navigation in patients with tortuous vessels.

Authors:  Tae Hong Lee; Chang Hwa Choi; Kyung-Pil Park; Sang Min Sung; Sang Won Lee; Byung-Hee Lee; Dong Hyun Kim; Hak Jin Kim; Chang Won Kim; Suk Kim
Journal:  AJNR Am J Neuroradiol       Date:  2005 Jun-Jul       Impact factor: 3.825

5.  Endovascular therapy of symptomatic intracranial stenosis in patients with impaired regional cerebral blood flow or failure of medical therapy.

Authors:  V Puetz; G Gahn; U Becker; D Mucha; A Mueller; N U Weir; B Wiedemann; R von Kummer
Journal:  AJNR Am J Neuroradiol       Date:  2007-11-07       Impact factor: 3.825

Review 6.  Angioplasty and stenting for atherosclerotic intracranial stenosis: rationale for a randomized clinical trial.

Authors:  Colin P Derdeyn; Marc I Chimowitz
Journal:  Neuroimaging Clin N Am       Date:  2007-08       Impact factor: 2.264

7.  New developments in clinical ischemic stroke prevention and treatment and their imaging implications.

Authors:  Jeremy J Heit; Max Wintermark
Journal:  J Cereb Blood Flow Metab       Date:  2017-02-14       Impact factor: 6.200

Review 8.  Stroke Caused by Atherosclerosis of the Major Intracranial Arteries.

Authors:  Chirantan Banerjee; Marc I Chimowitz
Journal:  Circ Res       Date:  2017-02-03       Impact factor: 17.367

9.  Transluminal angioplasty and stenting for intracranial vertebrobasilar occlusive lesions in acute stroke patients.

Authors:  K Imai; T Mori; H Izumoto; T Kunieda; N Takabatake; S Yamamoto; M Watanabe
Journal:  AJNR Am J Neuroradiol       Date:  2008-01-17       Impact factor: 3.825

10.  Outcome of endovascular treatment in symptomatic intracranial vascular stenosis.

Authors:  Dae Chul Suh; Sang Joon Kim; Duk Hee Lee; Won Kim; Choog Gon Choi; Jeong Hyun Lee; Hyun Jeong Kim; Sun Uck Kwon; Jong Sung Kim
Journal:  Korean J Radiol       Date:  2005 Jan-Mar       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.